$67.93 -0.77 (-1.13%)
2/10/2012 4:00 PM

Medivation, Inc. (NASDAQ:MDVN)

CAPS Rating: 1 out of 5

A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies.

Featured Broker Partners


Advertisement